[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20042850L - Kreftbehandling - Google Patents

Kreftbehandling

Info

Publication number
NO20042850L
NO20042850L NO20042850A NO20042850A NO20042850L NO 20042850 L NO20042850 L NO 20042850L NO 20042850 A NO20042850 A NO 20042850A NO 20042850 A NO20042850 A NO 20042850A NO 20042850 L NO20042850 L NO 20042850L
Authority
NO
Norway
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
Application number
NO20042850A
Other languages
English (en)
Inventor
Gail Rowlinson-Busza
Original Assignee
Antisoma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antisoma Plc filed Critical Antisoma Plc
Publication of NO20042850L publication Critical patent/NO20042850L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A61K51/1096Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20042850A 2002-01-12 2004-07-06 Kreftbehandling NO20042850L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0200657.5A GB0200657D0 (en) 2002-01-12 2002-01-12 Cancer treatment
PCT/GB2003/000105 WO2003057250A1 (en) 2002-01-12 2003-01-13 Cancer treatment

Publications (1)

Publication Number Publication Date
NO20042850L true NO20042850L (no) 2004-08-26

Family

ID=9928970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042850A NO20042850L (no) 2002-01-12 2004-07-06 Kreftbehandling

Country Status (16)

Country Link
US (1) US20050163707A1 (no)
EP (1) EP1465661A1 (no)
JP (1) JP2005520802A (no)
KR (1) KR20040091623A (no)
CN (1) CN1638797A (no)
AU (1) AU2003205813A1 (no)
BR (1) BR0306809A (no)
CA (1) CA2472893A1 (no)
GB (2) GB0200657D0 (no)
IL (1) IL162814A0 (no)
MX (1) MXPA04006747A (no)
NO (1) NO20042850L (no)
PL (1) PL371419A1 (no)
RU (1) RU2004124520A (no)
WO (1) WO2003057250A1 (no)
ZA (1) ZA200405414B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0519398D0 (en) * 2005-09-23 2005-11-02 Antisoma Plc Biological materials and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
GB9019553D0 (en) * 1990-09-07 1990-10-24 Unilever Plc Specific binding agents
US6333348B1 (en) * 1999-04-09 2001-12-25 Aventis Pharma S.A. Use of docetaxel for treating cancers
AU4430701A (en) * 2000-04-03 2001-10-15 Antisoma Research Limited Compounds for targeting

Also Published As

Publication number Publication date
GB0200657D0 (en) 2002-02-27
JP2005520802A (ja) 2005-07-14
CA2472893A1 (en) 2003-07-17
BR0306809A (pt) 2004-12-07
WO2003057250A1 (en) 2003-07-17
GB0300600D0 (en) 2003-02-12
GB2383538A (en) 2003-07-02
MXPA04006747A (es) 2006-01-30
EP1465661A1 (en) 2004-10-13
CN1638797A (zh) 2005-07-13
RU2004124520A (ru) 2005-03-20
AU2003205813A1 (en) 2003-07-24
KR20040091623A (ko) 2004-10-28
PL371419A1 (en) 2005-06-13
ZA200405414B (en) 2005-06-22
GB2383538B (en) 2003-11-19
US20050163707A1 (en) 2005-07-28
IL162814A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
DE60313805D1 (de) Steuerbarer Katheter
NO20052914D0 (no) Terapeutiske forbindelser
DE50203563D1 (de) Rollosystem
DE60333537D1 (de) Herzschrittmacher
EE05505B1 (et) Personaalne teraapiasektsioon
DE60317391D1 (de) Verbinder
DE60311298D1 (de) Kopfhautbehandlung
DE60301239D1 (de) Verbinder
DE60208885D1 (de) Verbinder
DE60315937D1 (de) Verbinder
DE60223352D1 (de) Verbinder
DK1597171T3 (da) Terapeutisk mikroskum
DE50303208D1 (de) Osteosyntheseeinrichtung
ATE442835T1 (de) Oberflächenbehandlung
DE10301279B8 (de) Verbinder
DK1553950T3 (da) Terapeutisk behandling
NO20050689L (no) Terapeutisk anvendelse
DE60312105D1 (de) Verbinder
DE60218623D1 (de) Verbinder
FR2837224B1 (fr) Bonde traitante
DE60229887D1 (de) Oberflächenbehandlungssystem
DE60311724D1 (de) Verbinder
DE60328516D1 (de) Thia-epothilon derivate zur krebsbehandlung
NO20053189D0 (no) HVC-kombinasjonsterapi.
NO20042850L (no) Kreftbehandling